Display Options:
Total: 1404
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Leukemia; Lymphoma
Unknown
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Proheparin-binding EGF-like growth factor inhibitor
Antibody
Investigational
Unknown
Unknown
Melanoma
Disialoganglioside GD2 cross-linking agent
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Lymphoma
CD22 binding agent
Antibody
Investigational
Unknown
Unknown
Dermatitis, Atopic; Rhinitis, Allergic, Seasonal
Ig epsilon chain C region inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
Antibody
Investigational
Unknown
Unknown
Central Nervous System Neoplasms
Elongation factor 2 inhibitor
Antibody
Investigational
Unknown
Unknown
Bone Diseases, Metabolic
Sclerostin inhibitor
Antibody
Investigational
Unknown
Unknown
Melanoma
5,6-dihydroxyindole-2-carboxylic acid oxidase other
Antibody
Investigational
Unknown
Unknown
Unknown
Glycoprotein inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms
Neuropilin-1 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Integrin beta-2 inhibitor
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms
Glutamate carboxypeptidase II binding agent
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; HIV Infections; Melanoma; Neoplasms; Ovarian Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung
Programmed cell death protein 1 inhibitor
Antibody
Unknown
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Autoimmune Diseases; Neoplasms; Lymphoma, Follicular
Unknown
Antibody
Investigational
Unknown
Unknown
Graft vs Host Disease
Unknown
Antibody
Investigational
Unknown
Unknown
Carcinoma
Epithelial cell adhesion molecule binding agent
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Pancreatic Neoplasms
Frizzled-1 antagonist
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Neoplasms
Teratocarcinoma-derived growth factor 1 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Selectin E inhibitor
Antibody
Investigational
Unknown
Unknown
Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Multiple Myeloma; Neoplasms; Waldenstrom Macroglobulinemia
C-X-C chemokine receptor type 4 inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Fibroblast activation protein alpha binding agent
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Glutamate carboxypeptidase II binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Interferon alpha-1/13 binding agent
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Multiple Myeloma; Plasmacytoma
HLA-DR antigens-associated invariant chain antagonist
Antibody
Investigational
Unknown
Unknown
Autoimmune Diseases; Immunoglobulin G4-Related Disease; Pemphigus; Anemia, Hemolytic, Autoimmune; Myasthenia Gravis
IgG receptor FcRn large subunit p51 antagonist